Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia

Abstract Background Acute promyelocytic leukaemia (APL) is a unique subtype of acute myeloid leukaemia (AML) characterized by haematopoietic failure caused by the accumulation of abnormal promyelocytic cells in bone marrow (BM). However, indispensable BM biopsy frequently afflicts patients in leukae...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Guiran Wang, Guiling Yan, Kanru Sang, Huijie Yang, Ni Sun, Yuanyuan Bai, Feng Xu, Xiaoqun Zheng, Zhanguo Chen
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2022-05-01
Серии:BMC Cancer
Предметы:
Lnc-LOC
Acute promyelocytic leukaemia
Minimal residual disease
Noninvasive biomarker
Surveillance
Online-ссылка:https://doi.org/10.1186/s12885-022-09621-1
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы